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Summary
Colonoscopy is the gold standard in diagnosis of colorectal cancer that in most instances 
arises from precursor lesion, adenomatous polyp. However, white ligh forward viewing colonos-
copy is not a pefect method, up to a quarter of adenomas are being missed during standard pro-
cedures. Therefore, new techniques and technologies are being developed in order to increase 
adenoma detection rate, either through better resolution and magnification of the image (high-
definition, high-magnification endoscopes) or by augmenting the overview of colonic mucosa 
(Full Spectrum Endoscopy colonoscope, Third-Eye Retroscope). Besides adenoma detection, 
new technologies allow better tissue characterisation and in vivo discrimination between non-
neoplastic and neoplastic lesions (conventional chromoendoscopy, virtual chromoendoscopy, 
confocal laser endomicroscopy, endocytoscopy). In additon to diagnostic procedures, therape-
utic techniques are also evolving. Formerly, all of the flat or depressed colorectal lesions, en-
countered during colonoscopy, were reffered to surgery. Today, endoscopic mucosal resection 
is becoming a routine method for the treatment of early gastrointestinal mucosal lesions of less 
than 2 cm in diameter. For larger lesions, endoscopic submucosal dissection, a state-of-the-art 
technique, is indicated, but currently carried out only in tertiary centres. 
Endoscopic innovations are leading into new era of colorectal cancer diagnosis and mana-
gement, hopefully resulting in decrease of incidence, morbidity and mortality.
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INTRODUCTION
Colorectal cancer (CRC) is second most common cancer among Croatian men 
and women and second leading cause of death from cancer [1,2]. It is also among 
five most common cancers worldwide and although it is more common in richer 
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countries, incidence of the disease is rising in some developing countries [2,3]. As 
opposed to other common cancers such as lung, breast and prostate, where the fo-
cus is early detection, CRC can be prevented since the majority of CRCs arise from 
precursor lesions, adenomatous polyps [4]. Indeed, studies have confirmed that re-
moval of adenomatous polyps leads to reduction of cancer and subsequent reduc-
tion of mortality [5]. Given the above, CRC screening is widely recommended with 
colonoscopy being the gold standard for CRC diagnosis [6]. However, standard whi-
te light forward viewing colonoscopy is not a perfect method, reported adenoma 
miss rates are up to 27% [7-12]. Therefore, new endoscopic techniques and technolo-
gies are being developed in order to reduce adenoma miss rates and the incidence 
of interval cancer. It is recommended for every colorectal lesion encountered on 
colonoscopy to be removed and examined by a pathologist, a costly strategy that 
increases the risk of polypectomy complications [6,13]. Regarding the latter, new 
technologies are emerging designed to enable in vivo tissue characterization (‘’op-
tical biopsies’’) and ‘’leave in situ’’ approach for hyperplastic polyps or ‘’resect and 
discard’’ approach for diminutive adenomatous polyps [14]. Information obtained 
by ‘’optical biopsies’’ also impact therapeutic strategy selection since tissue biopsies 
are not recommended prior to endoscopic mucosal resection (EMR) and endoscopic 
submucosal dissection (ESD). EMR and ESD are endoscopic techniques for removal 
of flat pre-cancerous and cancerous lesions, that can, in carfeully selected patients, 
replace surgery [15,16]. In this review we will perlustrate advances in endoscopy re-
garding colon cancer diagnosis and management. Even though some commercially 
accessible for more than a decade, many technologies are not widely available due to 
their price and the need for expertise in interventional gastroenterology.
ENDOSCOPIC INNOVATIONS IN COLON CANCER SCREENING
Colonoscopy is the gold standard in CRC screening however, for moderate risk 
population, it has its limitations. Patients percieve bowel preparation, crucial for 
adequate examination, upleasant, the procedure carries the small risk of bowel 
perforation and in case of sedation, cardiopulmonary complications. Accordingly, 
many adult patients opt for other, less invasive procedures including stool based 
tests (guiac-based fecal occult blood test, fecal immunochemical test, stool DNA 
test) and full or partial structural exams (flexible sigmoidoscopy, double-contrast 
barium enema, computed tomographic colonography) [6,13]. 
Currently, a new endoscopic procedure, colon capsule endoscopy (CCE), that 
may be useful for improving compliance with CRC screening, is being evaluated. 
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Even though similar to small bowel device, the capsule is bigger (11x32 mm vs. 
11x26 mm) with video capture components on both ends of the capsule. After initial 
activation, the colon capsule captures images for 5 minutes, then transits into sleep 
mode for 2 hours. Once reactivated, approximately at the level of terminal ileum, the 
capsule records images for about 10 hours. Data are recorded via an antenna - lead 
array similar to that used in other capsule endoscopy procedures. Images are then 
transferred from a recording device to a workstation for formal review and report 
generation.
CCE has been shown to be a safe procedure when used in average-risk individu-
als with a very low rate of technical failures (3%) and a high capsule excretion rate 
of about 90% [17,18]. 
As in all other forms of screening, any positive findings require conventional 
colonoscopy for tissue sampling or polypectomy.
Quality of screening colonoscopy is measured by adenoma detection rate and 
cecal intubation rate. Factors impacting procedure quality, besides bowel prepara-
tion and colonoscopist’s proficiency, include patient’s compliance conditioned by 
abdominal discomfort and pain, the presence of subtle, flat or depressed lesions 
that are difficult to detect with standard endoscopic equipment and lesion location 
in ‘’blind spots’’ of colonic mucosa [13]. 
When it comes to improving patient comfort and increasing cecal intubation 
rate, water infusion techniques and cap-assisted colonoscopy have shown promi-
sing results.
For appropriate mucosa visualization, colon folds need to be separated. Stan-
dard air insufflation colonoscopy provides good visualization but also distends and 
elongates the colon, increasing the likelihood of patient discomfort. Water infusion 
techniques (‘’water immersion’’ and ‘’water exchange’’) use water adjunct to air. Wa-
ter helps open colon folds with less comparative distention, which significantly re-
duces pain during colonoscopy, decreases the need for sedation drugs and increases 
the completion rate in patients with prior difficult colonoscopies [19-22].
Cap-assisted colonoscopy uses transparent caps attached to the distal tip of the 
colonoscope thus helping in depressing colonic folds in order to improve visualiza-
tion of their proximal aspects. It was initially suggested that the technique might 
be of benefit for polyp detection, however, studies did not confirm this hypothesis. 
They did however report reduced cecal intubation times and improved cecal intuba-
tion rates. The same accounted for procedures in patients in whom cecal intubation 
initially failed with standard colonoscopy [22,23].
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Standard forward viewing colonoscopes visualise the colon from the flexible tip 
of the instrument, with an angle of view up to 170° and as mentioned above a high 
adenoma miss rate is partially due to their inability to detect lesions hidden in the 
‘’blind spots’’, such as the internal lining of flexures and proximal aspects of folds. In 
order to surpass this obstacle and get a better overview of colonic mucosa, Full Spec-
trum Endoscopy (FUSE) colonoscope and Third-Eye Retroscope have been designed.
FUSE colonoscope allows a high resolution 330 degrees “full spectrum” viewing 
of the colonic lumen while maintaining technical features and capabilities of a stan-
dard 140 and 170 degrees colonoscope. 
The FUSE system consists of a main control unit and a video colonoscope with 
three cameras on the left-side, front and rightside of the flexible tip. Video images 
are displayed on three contiguous monitors corresponding with each individual 
camera [24-26]. 
Third-Eye Retroscope is a probe based device that is retroflexed 180 degrees 
after being advanced through the working channel of the colonoscope. It provides a 
135 degrees retrograde view of the colon on the same monitor as a forward viewing 
colonoscope. However there are some limitations inherent to the device that confine 
its use in every day practice. First, thorough suctioning of colonic debris must be 
done during insertion of the colonoscope due to a 50% reduced suctioning capacity 
when the retroscope is in position. A second disadvantage is that the Third-Eye Re-
troscope needs to be removed from the working channel in case an accessory device 
is required, such as a biopsy forces or a polypectomy snare, which is bothersome 
and increases the procedural time [22,27].
For both FUSE colonoscopy and Third-Eye Retroscope colonoscopy preliminary 
studies have reported significant reductions in the proportion of missed adenomas 
in comparison with standard 170 degrees view straight-forward colonoscopy, even 
though reductions were more modest with Third-Eye Retroscope than those descri-
bed for FUSE colonoscopy [22,24-27]. 
IMAGING INNOVATIONS FOR DETECTION AND DIFFERENTIATION OF 
COLORECTAL NEOPLASIA
The aim of colonoscopy is to detect adenomatous, pre-cancerous polyps, remove 
them and thus reduce CRC related morbidity and mortality. However, not all polpys 
are adenomatous but reliable differentiation between adenomatus and hyperplastic 
lesions is not possible solely according to the macroscopic lesion characteristics on 
white light illumination (accuracy 59-84%). Therefore, it has been recommended for 
all encountered lesions to be resected and submitted to pathology. New technologi-
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es enable better visualization (high-definition and high-magnification endoscopes) 
and enhanced characterization of lesions (conventional and virtual chromoendos-
copy, confocal laser endomicroscopy, endocytoscopy). Besides macroscopic features 
such as size and surface characteristics, microvascular pattern and pitt patern are 
being evaluated. With introduction of new parameters, endoscopists can more reli-
ably differentiate between neoplastic and non-neoplastic lesions, apply more econo-
mical ‘’leave in situ’’ or ‘’resect and discard’’ approach for small hyperplastic polyps 
and diminutive adenomas respectively, but also estimate the risk of submucosal 
invasion, crucial for guiding therapeutic decision on whether endoscopic or surgical 
operation will be carried out. 
The video capabilities of color images of standard definition endoscopes are ba-
sed on traditional television broadcast formats. Advances in technology have resul-
ted in increased number of pixels and increased resolution. Current high-resoluti-
on or high-definition endoscopes produce images with resolutions that range from 
850,000 pixels to more than 1 million pixels, allowing them to discriminate objects 
that are only 10 to 71 microns in diameter.
At baseline, standard-resolution and high-resolution endoscopes magnify the 
endoscopic images 30 to 35 times. High-magnification endoscopes are defined by 
the capacity to perform optical zoom using movable lens in the tip of the endoscope 
thus magnifying images up to 150 times [22,28].
Conventional chromoendoscopy (dye assisted colonoscopy) involves topical 
application of stains or pigments to highlight surface contours.
The procedure is carried out using standard endoscopic equipment in addition 
of a special spray catheter essential to deliver a fine mist of dye to the mucosa. In 
diagnosing colonic neoplasia methylene blue, crystal violet and, most commonly, 
indigo carmine, are used. 
Indigo carmine is a contrast stain that pools into crevices between epithelial ce-
lls, highlighting small or flat lesions and defining irregularities in mucosal architec-
ture, particularly when used with high-magnification or high-definition endoscopy. 
Pancolonic chromoendoscopy, recommended for neoplasia surveillance in pa-
tients with long-standing colitis [14], significantly increases the rate of detection of 
small neoplastic and flat lesions, but this technique requires an excessive volume 
of dye and a significantly prolonged procedure. Therefore, in average-risk patients, 
colonoscopists use “selective” chromoendoscopy for further examination of surface 
structure and mucosal crypt (pit) pattern of any subtle mucosal irregularity detec-
ted during standard colonoscopy [29]. 
Virtual chromoendoscopy refers to the use of image enhancement technologies 
built into the colonoscope system to alter the white-light image and enhance visu-
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alization of mucosal surface architecture and capillary pattern. All commercially 
available systems work differently, but have a key aim of reducing the amount of red 
light in the image and of narrowing the bandwidth of blue and green light.
Narrow band imaging (NBI) separates white light into red, green, and blue 
using a special optical filter. Red light is eliminated and the contribution of blue and 
green wavelengths increased. Since mucosal hemoglobin selectively absorbs blue 
light, and the mucosa surrounding blood vessels reflects it, the contrast of the ima-
ge is increased and the mu cosal micro-vessel architecture can be estimated in fine 
detail. In the colon and rectum, microvessels form a ring, and each ring surrounds 
its respective gland. A deformed microvessel suggests a deformed neoplastic gland. 
Neoplastic changes re sult in a change in the form, density, and size of microvessels, 
and colorectal lesions can therefore be diagnosed [31,32].
FUJINON Intelligent Color Enhancement (FICE) is a computed spectral esti-
mation technology that enhances the visibility of mucosal and vascular details by 
narrowing the bandwidth of light. FICE enables the endoscopist to choose between 
different wavelengths for optimal examination of the colon mucosa [14,22].
I-SCAN utilizes the same spectral estimation technology as FICE technology, 
and applies a digital color filter to images to emphasize lesions [14,22]. 
Even though the effect of pancolonic virtual chromoendoscopy on adenoma and 
polyp detection seems limited studies have reported high accuracy of both con-
ventional and virtual chromoendoscopy (NBI, FICE and i-SCAN) [14, 30-32] in di-
fferentiation between adenomatous and hyperplastic polyps, therefore, European 
Society of Gastrointestinal Endoscopy suggests that they can be used, under strictly 
controlled conditions, for real-time optical diagnosis of diminutive (≤5mm) colorec-
tal polyps to replace histopathological diagnosis [14]. 
Autofluorescence imaging (AFI) endoscopy is based on real-time detection of 
natural tissue fluorescence emitted by endogenous molecules, after excited by a 
certain wavelength. Differences in fluorescence emission between neoplastic and 
non-neoplastic tissues are captured during endoscopy and visualized as magenta 
or green color, respectively. The device is activated by a push-button on the handle 
of the endoscope. Recently, AFI has been connected to a high-resolution endoscope 
and to the NBI system, giving rise to a combined modality called endoscopic tri-
modal imaging. However, as opposed to above mentioned technologies, studies on 
benefit of AFI reported conflicting results [14,22,33,34]. 
Confocal laser endomicroscopy (CLE) and endocytoscopy are emerging endos-
copic technologies that permit high-resolution assessment of gastrointestinal muco-
sal histology.
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Confocal laser endomicroscopy provides microscopic images during ongoing en-
doscopy that trained endoscopists are able to evaluate on-site. The technology is ba-
sed upon the principle of illuminating a tissue of interest with a low-power laser and 
then detecting fluorescent light reflected from the tissue. Intravenous injection of flu-
orescin is used to highlight the vasculature, lamina propria, and intracellular spaces 
of tissue being examined, in addition of topical acriflavine for nuclei staining [35-37]. 
Similar to CLE, endocytoscopy aims to enable real-time microscopic imaging of 
the mucosa in vivo. The main difference between CLE and endocytoscopy is that 
endocytoscopy is based solely on high-level magnification using optical lenses and 
only the very superficial layer of the mucosa can be imaged. In addition, the lens 
must come into direct contact with the tissue being examined. As with confocal en-
domicroscopy, acquisition of quality images requires application of a contrast agent. 
Typically, topical application of methylene blue or a combination of methylene blue 
with crystal violet is used [35].
For both CLE and endocystoscopy, probe-based systems are commercially ava-
ilable. The indications are still being defined. In general, these procedures are used 
to target biopsies of abnormal tissue and decrease biopsies of normal tissue [35]. 
ENDOSCOPIC INNOVATIONS IN EXCISION PROCEDURES FOR  
COLORECTAL LESIONS
Endoscopic treatment is recommended for benign lesions and early colorectal 
tumors with no evidence of enlarged lymph nodes or lymph node metastasis. 
There are various established polypectomy techniques for endoscopic removal 
of polypoid colorectal lesions carried out in most of the gastroenterology centers. 
When it comes to flat or depressed colorectal lesions and laterally spreading tumors 
(LSTs), before the introduction of endoscopic mucosal resection (EMR) and endos-
copic submucosal dissection (ESD), the latter currently performed only in tertiary 
centers, patients have been reffered to surgery with outcomes such as hemicolecto-
my or stoma formation, that greatly impacted the quality of life. 
Careful characterization of lesions is mandatory in order to avoid incomplete 
treatment or unnecessary surgery. While lesions confined to superficial mucosa and 
up to 20 mm in diameter can be successfully treated with EMR, larger ones with 
higher possibility of submucosal invasion require ESD with en bloc resection for an 
accurate pathological evaluation. In cases of submucosal invasion of less than 1000 
microns where the risk of lymph node metastasis is less than 1%, ESD is considered 
therapeutical. On the other hand, for deeper invasion, the risk is substantially incre-
ased, therefore, in such cases ensuing surgery is warranted [15]. 
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Predictors of submucosal invasion, besides size [38], evaluated using convential 
or virtual chromoendoscopy with high definition-high magnification colonosco-
pe, include invasive type pit pattern, distorted capillary architecture and nodular 
mixed or pseudo-depressed LST surface morphology [15,39].
EMR, even though technically more difficult than standard polypectomy, is con-
sidered its variation and has become a routine method for the treatment of early 
gastrointestinal mucosal lesions. Typically, after marking the margins with electro-
cautery, a solution is injected into the submucosa to lift the lesion for easier removal 
and to provide a cushion to help protect the deeper layers of the bowel wall from 
mechanical or electrocautery damage followed by lesion resection using a mucosec-
tomy device (grasping forceps, electrocautery snare, ligation device). The improved 
version of EMR, EMR with pre-cutting, is applied when the tumor location is not 
convenient for the traditional EMR operation [15,16,40]. 
EMR en block resection is feasible for lesions up to 20 mm but for larger ones, 
EMR can only be conducted in piecemeal fashion. Since piecemeal resection carri-
es a high risk of local reccurence (0-55%) and prevents pathologist from reliably 
determining the status of the resection margins, intensive post-EMR colonoscopic 
surveillance is required (follow up at 2 to 6 months) [16]. 
ESD is indicated for larger lesions in which en block resection using EMR is 
difficult. It is usually limited to lesions up to 5 cm in diameter but Japanese refferal 
centers have reported performing ESD on even larger ones. Further indications for 
colorectal ESD include mucosal tumors with fibrosis, scattered tumors caused by 
chronic inflammation and residual early tumor lesions after endoscopic operation. 
The procedure involves visualization of the edges using virtual chromoendos-
copy, marking the edges with argon knife, applying multipoint injections of pre-
prepared solution into submucosal tissue. The edge of the lesion is then cut and the 
lesion stripped using special ESD knives (various knives are commercially available 
e.g. IT knife, Hook knife, Flex knife, B-knife, Flush-knife, Scissor-type knife, toung-
type knife) [41]. The improved technique of ESD, ESD-S, uses a snare insted of the 
ESD knife to strip the lesion [15,16,40,41]. 
Complications of both EMR and ESD include bleeding, perforation and local 
reccurence. Various studies have reported the rates of EMR and ESD complications 
(perforation rate: EMR: 0-1.3%, ESD 0-8%; postoperative bleeding: ESD EMR 3.6-
8.1%, ESD 0.4-11.5%; local tumor reccurence: EMR 0.8-18.1%, ESD 0.4-2%) as well as 
resection rates (en-block resection: EMR 42.4%, ESD 74-89%) [42-51]. However, the 
data are hard to compare since indications and the intrinsic aggressiveness of two 
technques on bowel wall differ. The risk of complications, as well as procedure time 
(ESD 108±71 min, EMR 29±25) [45], increase with tumor size and unfavorable loca-
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tion (procedures are more feasible in rectum compared to colon) [51], but also, over 
the years, complication rates reported are decreasing.
Overall, EMR is superior to ESD in treatment of benign colorectal lesions since 
it has low risk of complications, shorter operation time and the characteristics of 
the operation are relatively simple. However, in case of suspected early carcinoma 
it is very important to mandate complete resection. ESD has higher resection rate 
and lower reccurence compared with EMR and provides a better quality of life for 
patients compared to surgery. 
CONCLUSION
New endoscopic techniques and technologies, compared to standard endosco-
pic equipment, have increased adenoma detection rate and enabled better in vivo 
characterization of lesions. Also, many experts believe that state-of-the-art tech-
niques in treatment of early colorectal cancer will replace surgery and thus improve 
patient’s quality of life. Endoscopic innovations are leading into new era of colo-
rectal cancer sreening and management, hopefully resulting in reduction of CRC 
incidence, morbidity and mortality. 
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Sažetak
Endoskopske inovacije u dijagnostici i liječenju kolorektalnog karcinoma
Kolonoskopija je zlatni standard u dijagnostici kolorektalnog karcinoma koji u većini sluča-
jeva nastaje iz prekursorske lezije, adenoma. Međutim, standardna kolonoskopija nije savršena 
metoda; prema rezultatima tandem studija čak četvrtina adenoma ostaje neotkrivena. Stoga se 
razvijaju nove tehnike i tehnologije koje omogućuju bolju detekciju adenoma uvećanjem i bo-
ljom rezolucijom slike (‘’high-definition’’, ‘’high-magnification’’ endoskopi) te boljim pregledom 
sluznice debelog crijeva (‘’Full Spectrum Endoscopy’’ kolonoskop, ‘’Third-Eye Retroscope’’). 
Nove tehnologije također omogućuju i napredniju karakterizaciju kolorektalnih promjena i in 
vivo razlikovanje ne-neoplastičnih i neoplastičnih lezija (konvencionalna kromoendoskopija, 
virtualna kromoendoskopija, konfokalna laserska endomikroskopija, endocitoskopija). Osim di-
jagnostičkih, napreduju i terapijske endoskopske metode. Do sada su sve ne-polipoidne kolo-
rektalne promjene liječene kirurški, a danas je endoskopska mukozna resekcija postala rutinska 
metoda za lezije do 2 cm u promjeru. U slučaju većih promjena inidicirana je endoskopska sub-
mukozna disekcija, state-of-the-art tehnika koja se trenutno izvodi samo u tercijarnim centrima. 
Inovacije u endoskopiji vode u novu eru dijagnostike i liječenja kolorektalnog karcinoma te 
nagoviještaju bolju prevenciju i smanjenje incidencije ove česte maligne bolesti. 
Ključne riječi: kolorektalni karcinom; dijagnostika; liječenje kolorektalnog karcinoma; kolo-
noskopija; inovacije.
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